ArticleAnnals of the American Thoracic Society2021
Maximal Exercise Testing Using the Incremental Shuttle Walking Test Can Be Used to Risk-Stratify Patients with Pulmonary Arterial Hypertension.
Open access · hybridAbstract read
In one paragraph
Article in Annals of the American Thoracic Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
1.6field-weighted citation impact, top 13% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 24 citations in OpenAlex.
- Prognostic Value of Serial Risk Stratification in Adult and Pediatric Pulmonary Arterial Hypertension: A Systematic Review.Journal of the American Heart Association · 2024Pooled it
- Risk stratification in adult and pediatric pulmonary arterial hypertension: A systematic review.Frontiers in cardiovascular medicine · 2022Pooled it
- Assessing the feasibility of using smartphone data to identify risk of idiopathic pulmonary arterial hypertension.NPJ cardiovascular health · 2026Article
- Article
- NT-proBNP and BNP Testing in Pulmonary Arterial Hypertension: Point-of-Care and Remote Monitoring.Respirology (Carlton, Vic.) · 2025Observational
- Exercise pulmonary hypertension in chronic thromboembolic pulmonary disease: A right heart catheterization study.Pulmonary circulation · 2024Article
- Individualized survival predictions using state space model with longitudinal and survival data.Journal of the Royal Society, Interface · 2024Article
- Association of risk assessment at diagnosis with healthcare resource utilization and health-related quality of life outcomes in pulmonary arterial hypertension.Pulmonary circulation · 2024Article
- Observational
- Establishing minimally important differences for cardiac MRI end-points in pulmonary arterial hypertension.The European respiratory journal · 2023Article
- Pulmonary Hypertension and Measurement of Exercise Capacity Remotely: Evaluation of the 1-min Sit-to-Stand Test (PERSPIRE) - a cohort study.ERJ open research · 2023Article
- Telehealth: A winning weapon to face the COVID-19 outbreak for patients with pulmonary arterial hypertension.Vascular pharmacology · 2022Article
- Machine learning cardiac-MRI features predict mortality in newly diagnosed pulmonary arterial hypertension.European heart journal. Digital health · 2022Article
- Shuttling toward Improved Clinic-based Assessment of Exercise Capacity in Pulmonary Arterial Hypertension.Annals of the American Thoracic Society · 2021Article
Corrections and comments
- Commented on by
Authors and funding
20 authors at 3 institutions in 1 country.
Robert A LewisSheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.
Catherine G BillingsSheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.
Judith A HurdmanSheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.
Ian A SmithSheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.
Matthew AustinSheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.
Iain J ArmstrongSheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.
Jennifer MiddletonSheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.
Alexander M K RothmanSheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.
John HarringtonSheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.
Neil HamiltonSheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.
Abdul G HameedSheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.
A A Roger ThompsonSheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.ORCID 0000-0002-0717-4551
Athanasios CharalampopoulosSheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.
Charlie A ElliotSheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.
Allan LawrieDepartment of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Sheffield, United Kingdom; and.
Ian SabroeSheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.
Jim M WildDepartment of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Sheffield, United Kingdom; and.
Andrew J SwiftDepartment of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Sheffield, United Kingdom; and.
Robin CondliffeSheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.
David G KielySheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.
National Health Service · GBInsigneo · GBUniversity of Sheffield · GB
Funding
British Heart Foundation FS/18/13/3328British Heart Foundation FS/18/13/33281British Heart Foundation FS/18/52/33808British Heart Foundation SP/14/6/31350Medical Research Council MR/M008894/1Wellcome TrustWellcome Trust 205188/Z/16/ZWellcome Trust 206632/Z/17/Z
Abstract
PubMed holds no abstract for this paper.
Indexed as
Exercise TestPulmonary Arterial HypertensionWalk TestHumansexercise testingoutcomerisk stratification
Identifiers
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.